Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer

Clinical trial NCT00349557 · COMPLETED

Trial details

NCT number: NCT00349557
Sponsor: Benaroya Research Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2006-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.